Filter by: patients
Home > Community Treatment Reports and Side Effects > Efavirenz-Emtricitabine-Tenofovir Treatment Report
What is Efavirenz-Emtricitabine-Tenofovir?

The antiretroviral drugs efavirenz, emtricitabine, and tenofovir are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 424 155 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Support immune health 14 9 Efficacy_major Efficacy_moderate
Other 9 2 Efficacy_major
General health 6 2 Efficacy_major Efficacy_moderate
low CD4 3 1 Efficacy_major
Don't know 2 1 Efficacy_none

See all 441 patients currently taking Efavirenz-Emtricitabine-Tenofovir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 26
Moderate
 32
Mild
 68
None
 35

Commonly reported side effects, conditions, and hospitalizations associated with Efavirenz-Emtricitabine-Tenofovir

Vivid dreams 65
Dizziness 59
Tiredness 34
Inconsistent sleep pattern 27
Balance problems 15
Rash or skin problems 14
See all 73 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Efavirenz-Emtricitabine-Tenofovir. See all 20 dosages ►

  daily 1 tbs. daily 1 daily 200 mg daily 500 mg daily 600 daily 600 mg-200 mg-300 mg daily 600 mg daily 1,100 mg daily 1,200 mg daily
  29 Number of Patients: 29 5 Number of Patients: 5 12 Number of Patients: 12 4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 334 Number of Patients: 334 27 Number of Patients: 27 4 Number of Patients: 4 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Efavirenz-Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 39   Side effects too severe: 60%
Doctor's advice 17   Doctor's advice: 26%
Other 9   Other: 14%
Personal research 4   Personal research: 6%
Not indicated 3   Not indicated: 5%
Did not seem to work 3   Did not seem to work: 5%
Course of treatment ended 1   Course of treatment ended: 2%
Change in health plan coverage 1   Change in health plan coverage: 2%
Expense 1   Expense: 2%

See all 63 patients who’ve stopped taking Efavirenz-Emtricitabine-Tenofovir

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Efavirenz-Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Efavirenz-Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Efavirenz-Emtricitabine-Tenofovir

Always
 148 92%
Usually
 10 6%
Sometimes
 1 1%
Never
 2 1%

Burden

Difficulty being on treatment

Burden of Efavirenz-Emtricitabine-Tenofovir

Very
 9 6%
Somewhat
 16 10%
A little
 28 17%
Not at all
 108 67%

Cost

Paid out of pocket

Cost of Efavirenz-Emtricitabine-Tenofovir

$200+
 10 8%
$100-199
 5 4%
$50-99
 22 17%
$25-49
 22 17%
< $25
 69 53%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.